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Aspirin is known to exert cytoprotection by presently uni-
dentified mechanisms. This study investigates the involve-
ment of the NO/cGMP-system and its downstream target
heme oxygenase-1 in mediating aspirin-dependent cyto-
protection. Hydrogen peroxide markedly reduced viabil-
ity of cultured endothelial cells derived from bovine
pulmonary artery. Preincubation with aspirin (3 to 30
µM, 12 hours) protected endothelial cells from hydrogen
peroxide-mediated toxicity and increased viability in a
concentration-dependent fashion. This effect was specific
in that other nonsteroidal anti-inflammatory drugs, such
as salicylate or indomethacin, did not alter hydrogen per-
oxide toxicity. Aspirin-induced endothelial protection was
abrogated in the presence of the NO scavenger PTIO (30
µM) and the inhibitor of soluble guanylyl cyclase ODQ (1
µM). Moreover, the L-arginine antagonist L-NMMA (25
µM), but not its D-enantiomer, led to complete inhibition
of aspirin-dependent cytoprotection. Correspondingly,
aspirin enhanced endothelial NO synthase activity (citrul-
line formation) as well as intracellular cGMP accumula-
tion. Cyclic GMP increases by both, aspirin and
exogenous nitric oxide, were synergistically enhanced in
the presence of YC-1, an NO-independent activator of sol-
uble guanylyl cyclase. These observations corroborate the
involvement of nitric oxide in aspirin-dependent cGMP
stimulation. Aspirin-dependent NO synthase activation
was associated with increased heme oxygenase-1 protein
expression and enzymatic activity. Pretreatment with
bilirubin, an heme oxygenase product with antioxidant
properties, produced protective effects similar to those
observed under the influence of aspirin or NO. Our data
demonstrate that endothelial NO synthase is a site of
action of aspirin and that the NO/cGMP-system assumes
a crucial function in mediating the cytoprotective action
of aspirin. Moreover, these findings support the concept
that NO-regulated antioxidant proteins such as heme oxy-
genase-1 contribute to endothelial protection by aspirin.
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